| 000 | 01675 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516085226.0 | ||
| 264 | 0 | _c20121031 | |
| 008 | 201210s 0 0 eng d | ||
| 022 | _a1095-6859 | ||
| 024 | 7 |
_a10.1016/j.ygyno.2012.04.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMatulonis, Ursula A | |
| 245 | 0 | 0 |
_aSequential bevacizumab and oral cyclophosphamide for recurrent ovarian cancer. _h[electronic resource] |
| 260 |
_bGynecologic oncology _cJul 2012 |
||
| 300 |
_a41-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 | _aBevacizumab |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPereira, Lauren | |
| 700 | 1 | _aLiu, Joyce | |
| 700 | 1 | _aLee, Hang | |
| 700 | 1 | _aLee, Julie | |
| 700 | 1 | _aWhalen, Christin | |
| 700 | 1 | _aCampos, Susana | |
| 700 | 1 | _aAtkinson, Tina | |
| 700 | 1 | _aHill, Margaret | |
| 700 | 1 | _aBerlin, Suzanne | |
| 773 | 0 |
_tGynecologic oncology _gvol. 126 _gno. 1 _gp. 41-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ygyno.2012.04.003 _zAvailable from publisher's website |
| 999 |
_c21689491 _d21689491 |
||